• 1
    Hermaszewski RA & Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Quart J Medicine 1993; 86:31 42.
  • 2
    Cunningham-Rundles C & Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34 48.DOI: 10.1006/clim.1999.4725
  • 3
    Kondratenko I, Amlot PL, Webster AD, Farrant J. Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. Clin Exp Immunol 1997; 108:9 13.
  • 4
    Eckert K, Schmitt M, Garbin F, Wahn U, Monier JC. Thymosin alpha 1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: preliminary results. Int J Immunopharmacol 1994; 16:1019 25.
  • 5
    Jaffe JS, Strober W, Sneller MC. Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Blood 1993; 82:192 200.
  • 6
    Spickett GP, Farrant J, North ME, Zhang JG, Morgan L, Webster AD. Common variable immunodeficiency: how many diseases? Immunol Today 1997; 18:325 8.DOI: 10.1016/s0167-5699(97)01086-4
  • 7
    Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361:226 33.
  • 8
    Robertson MJ & Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76:2421 38.
  • 9
    Leite-De-Moraes MC & Dy M. Natural killer T cells: a potent cytokine-producing cell population. Eur Cytokine Network 1997; 8:229 37.
  • 10
    Schlenke P, Frohn C, Klueter H et al. Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres. Cytometry 1998; 33:310 7.DOI: 10.1002/(sici)1097-0320(19981101)33:3<310::aid-cyto4>;2-k
  • 11
    Sewell WA, North ME, Webster AD, Farrant J. Determination of intracellular cytokines by flow-cytometry following whole-blood culture. J Immunol Methods 1997; 209:67 74.DOI: 10.1016/s0022-1759(97)00150-6
  • 12
    Ritz J, Schmidt RE, Michon J, Hercend T, Schlossman SF. Characterization of functional surface structures on human natural killer cells. Adv Immunol 1988; 42:181 211.
  • 13
    Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47:187 376.
  • 14
    Carson WE, Fehniger TA, Caligiuri MA. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur J Immunol 1997; 27:354 60.
  • 15
    Ronn LC, Hartz BP, Bock E. The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system. Exp Gerontol 1998; 33:853 64.DOI: 10.1016/s0531-5565(98)00040-0
  • 16
    Wright JJ, Wagner DK, Blaese M, Hagengruber C, Waldmann TA, Fleisher TA. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 1990; 76:2046 51.
  • 17
    Farrant J, Spickett G, Matamoros N et al. Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID). Immunodeficiency 1994; 5:159 69.
  • 18
    Crockard AD, Boyd NA, McNeill TA, McCluskey DR. CD4 lymphocyte subset abnormalities associated with impaired delayed cutaneous hypersensitivity reactions in patients with X-linked agammaglobulinaemia. Clin Exp Immunol 1992; 88:29 34.
  • 19
    Gupta S. Deficiency of monoclonal antibody-defined NK cells (HNK-1+) in primary immunodeficiency disorders. Immunol Letters 1982; 5:327 9.
  • 20
    Ohno T, Kanoh T, Suzuki T et al. Comparative analysis of lymphocyte phenotypes between carriers of human immunodeficiency virus (HIV) and adult patients with primary immunodeficiency using two-color immunofluorescence flow cytometry. Tohoku J Exp Med 1988; 154:157 72.
  • 21
    Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 1983; 131:1789 96.
  • 22
    Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. J Exp Med 1992; 175:1055 66.
  • 23
    Baumert E, Wolff-Vorbeck G, Schlesier M, Peter HH. Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1992; 90:25 30.
  • 24
    Spickett GP, Zhang JG, Green T, Shrimankar J. Granulomatous disease in common variable immunodeficiency: effect of immunoglobulin replacement therapy and response to steroids and splenectomy. J Clin Pathol 1996; 49:431 4.
  • 25
    De Vries E, Koene HR, Vossen JM et al. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. Blood 1996; 88:3022 7.
  • 26
    Kinlen LJ, Webster AD, Bird AG et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985; 1:263 6.
  • 27
    Filipovich AH & Shapiro RS. Tumors in patients with common variable immunodeficiency. J Immunol Immunopharmacol 1991; 11:43 46.
  • 28
    Finberg RW, Newburger JW, Mikati MA, Heller AH, Burns JC. Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood. J Pediatr 1992; 120:376 80.
  • 29
    Rigal D, Vermot-Desroches C, Heitz S, Bernaud J, Alfonsi F, Monier JC. Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules. Clin Immunol Immunopathol 1994; 71:309 14.DOI: 10.1006/clin.1994.1091
  • 30
    Engelhard D, Waner JL, Kapoor N, Good RA. Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J Pediatr 1986; 108:77 81.
  • 31
    Sulica A, Gherman M, Galatiuc C, Manciulea M, Herbermann R. Inhibition of human natural killer cell activity by cytophilic immunoglobulin G. J Immunol 1982; 128:1031 6.
  • 32
    Edberg JC & Kimberly RP. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding. J Immunol 1997; 159:3849 57.
  • 33
    Vitale M, Zamai L, Neri LM, Manzoli L, Facchini A, Papa S. Natural killer function in flow cytometry: identification of human lymphoid subsets able to bind to the NK sensitive target K562. Cytometry 1991; 12:717 22.
  • 34
    Rutella S, Rumi C, Lucia MB, Etuk B, Cauda R, Leone G. Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens. Immunol Letters 1998; 60:51 55.
  • 35
    Schmidt-Wolf IG, Blume KG, Johnston V, Huhn D, Negrin RS. Propagation of large numbers of T cells with natural killer cell markers. Br J Haematol 1994; 87:453 8.
  • 36
    Latthe M, Terry L, MacDonald TT. High frequency of CD8 alpha alpha homodimer-bearing T cells in human fetal intestine. Eur J Immunol 1994; 24:1703 5.
  • 37
    Rust C, Orsini D, Kooy Y, Koning F. Reactivity of human gamma delta T cells to staphylococcal enterotoxins: a restricted reaction pattern mediated by two distinct recognition pathways. Scand J Immunol 1993; 38:89 94.
  • 38
    Teahon K, Webster AD, Price AB, Weston J, Bjarnason I. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 1994; 35:1244 9.